Chemoresistance in Pancreatic Cancer The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes /

Drug resistance is a significant challenge in pancreatic ductal adenocarcinoma (PDAC), where stromal elements such as adipose-derived mesenchymal stem cells (ASCs) contribute to a chemoresistant tumor microenvironment (TME). This study explored the effects of oxaliplatin (OXP) and 5-fluorouracil (5-...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Parvaneh Shahram
Miklós Vanda
Páhi Zoltán Gábor
Szűcs Diána
Monostori Tamás
Póliska Szilárd
Venglovecz Viktória
Pankotai Tibor
Kemény Lajos
Veréb Zoltán
Dokumentumtípus: Cikk
Megjelent: 2025
Sorozat:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 26 No. 1
Tárgyszavak:
doi:10.3390/ijms26010390

mtmt:35667146
Online Access:http://publicatio.bibl.u-szeged.hu/35509
LEADER 02841nab a2200337 i 4500
001 publ35509
005 20250114101856.0
008 250114s2025 hu o 000 eng d
022 |a 1661-6596 
024 7 |a 10.3390/ijms26010390  |2 doi 
024 7 |a 35667146  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a eng 
100 1 |a Parvaneh Shahram 
245 1 0 |a Chemoresistance in Pancreatic Cancer  |h [elektronikus dokumentum] :  |b The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes /  |c  Parvaneh Shahram 
260 |c 2025 
300 |a 28 
490 0 |a INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES  |v 26 No. 1 
520 3 |a Drug resistance is a significant challenge in pancreatic ductal adenocarcinoma (PDAC), where stromal elements such as adipose-derived mesenchymal stem cells (ASCs) contribute to a chemoresistant tumor microenvironment (TME). This study explored the effects of oxaliplatin (OXP) and 5-fluorouracil (5-FU) on PDAC cells (Capan-1) and ASCs to investigate the mechanisms of chemoresistance. While OXP and 5-FU reduced Capan-1 viability in a dose- and time-dependent manner, ASCs demonstrated high resistance, maintaining > 90% viability even at cytotoxic doses. Transcriptomic analyses revealed OXP-induced transcriptional reprogramming in ASCs, with over 7000 differentially expressed genes, highlighting the pathways related to DNA damage response, cell cycle regulation, and stress-related signaling. In contrast, 5-FU elicited limited transcriptional changes, affecting only 192 genes. Cytokine proteome profiling revealed that OXP-treated ASCs significantly influenced the tumor microenvironment by promoting immune evasion (via IL-4, GM-CSF, IP-10, and GROα) and driving extracellular matrix remodeling (through EMMPRIN and DPPIV). In contrast, 5-FU induced comparatively weaker effects, primarily limited to hypoxia-related pathways. Although OXP reduced angiogenic factors, it paradoxically activated pro-survival pathways, thereby enhancing ASC-mediated tumor support. These findings underscore ASCs as modulators of chemoresistance via secretome alterations and stress adaptation. Therefore, future strategies should prioritize the precise targeting of tumor cells while also focusing on the development of personalized treatments to achieve durable therapeutic responses in PDAC. 
650 4 |a Biológiai tudományok 
650 4 |a Általános orvostudomány 
700 0 1 |a Miklós Vanda  |e aut 
700 0 1 |a Páhi Zoltán Gábor  |e aut 
700 0 1 |a Szűcs Diána  |e aut 
700 0 1 |a Monostori Tamás  |e aut 
700 0 1 |a Póliska Szilárd  |e aut 
700 0 1 |a Venglovecz Viktória  |e aut 
700 0 1 |a Pankotai Tibor  |e aut 
700 0 1 |a Kemény Lajos  |e aut 
700 0 1 |a Veréb Zoltán  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/35509/1/Parvaneh.pdf  |z Dokumentum-elérés